Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)
ID: 351636Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Income Security and Social Services

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/351636

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-24-075.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering the Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) to support innovative research projects led by Early Stage Investigators (ESIs). This grant aims to encourage ESIs to explore new research directions without the necessity of preliminary data, requiring applications to demonstrate a clear deviation from prior research and align with the scientific missions of participating NIH Institutes and Centers. The initiative emphasizes workforce diversity and is part of NIH’s commitment to advancing health research and innovation, with applications undergoing a peer review process based on significance, investigator qualifications, innovation, and overall approach. Interested applicants can find more information and submit their proposals by December 28, 2026, and should direct inquiries to grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-24-075-Full-Announcement.html
    PAR-24-075.html
    The Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) is a funding opportunity provided by the National Institutes of Health (NIH) to support innovative research projects led by Early Stage Investigators (ESIs). The grants aim to encourage ESIs to explore new research directions without requiring preliminary data. Accepted applications must demonstrate a clear deviation from prior research and align with the scientific missions of one or more participating NIH Institutes and Centers. Key details include application submission deadlines, eligibility criteria, funding amount (not limited but must be justified), and the project duration, which can last up to five years. The proposals undergo a peer review process, assessing significance, investigator qualifications, innovation, and overall approach. Applications must adhere to strict guidelines, including no inclusion of preliminary data, which could disqualify them. The initiative emphasizes workforce diversity, encouraging applicants from underrepresented backgrounds. It constitutes part of NIH’s commitment to advancing health research and innovation, ensuring compliance with relevant administrative policies, and facilitating effective data management and sharing practices. Overall, the grant serves as a platform for fresh, impactful research from emerging scientists.
    Similar Opportunities
    Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Human Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Humans Required) to support innovative research projects by early stage investigators (ESIs) that represent a significant change in research direction without the inclusion of preliminary data. This grant aims to encourage ESIs to explore new avenues in basic science experimental studies involving human subjects, aligning with NIH's definition of clinical trials. The opportunity emphasizes diversity and inclusivity, inviting applications from a wide range of eligible applicants, including higher education institutions and community-based organizations, with application deadlines extending until December 29, 2026. Interested applicants can find more information and application details at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Maximizing Investigators Research Award (MIRA) for Early Stage Investigators (ESI) (R35 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Maximizing Investigators' Research Award (MIRA) aimed at Early Stage Investigators (ESIs) under the Notice of Funding Opportunity (NOFO) PAR-23-145. This grant supports a comprehensive research program within the mission of the National Institute of General Medical Sciences (NIGMS), allowing eligible researchers to apply for up to $250,000 per year for a maximum of five years, with a requirement to dedicate at least 51% of their research efforts to the program. The MIRA program is designed to enhance scientific productivity and flexibility, enabling early-career scientists to explore significant research projects without the need for preliminary data, while also promoting diversity through a required Plan for Enhancing Diverse Perspectives (PEDP). Interested applicants should note that the application deadline is February 3, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)" aimed at supporting Early Stage Investigators (ESIs) in conducting innovative preclinical research on HIV/AIDS using NHP models. This grant initiative seeks to empower researchers who are within ten years of their terminal degree and have at least two years of postdoctoral experience, enabling them to explore new research directions that align with the NIH Strategic Plan for HIV and HIV-Related Research for FY 2021-2025. The funding provides a maximum of $400,000 over a two-year period, with applications due by September 7, 2025. Interested applicants can find more information and submission guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the "Small Grants for New Investigators to Promote Diversity in Health-Related Research" (R21 Clinical Trial Optional) to support new investigators from diverse backgrounds in conducting small research projects. This funding opportunity aims to facilitate the transition to independent research careers for individuals who have not previously secured over $125,000 in direct costs of research funding, specifically targeting those from historically underrepresented groups in biomedical research. The grants, which can last up to three years with a maximum direct cost of $125,000 annually, are intended to foster innovation and address health disparities in underserved populations. Interested applicants must submit their proposals by January 8, 2025, and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    Catalyst Award for Early-Stage Investigators (ESIs) Pursuing Research on HIV Comorbidities, Coinfections, and Complications (DP1- Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the Catalyst Award for Early-Stage Investigators (ESIs) pursuing innovative research on HIV comorbidities, coinfections, and complications. This funding opportunity aims to support pioneering studies that explore unique biological pathways affecting health outcomes for individuals with HIV, encouraging applicants to propose novel research that diverges from their existing programs. The initiative reflects NIH's commitment to advancing HIV research, with a funding ceiling of $350,000 per year for a project period of up to five years. Interested applicants should note that the application deadline is May 1, 2025, and can direct inquiries to grantsinfo@nih.gov for further information.
    NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Pathway to Independence Award (K99/R00), a federal grant aimed at supporting postdoctoral researchers in their transition to independent faculty positions. This program is designed to provide up to five years of funding, divided into two phases: the K99 phase for mentored training and the R00 phase for independent research, specifically targeting individuals with no more than four years of postdoctoral experience. The initiative emphasizes the importance of cultivating a diverse and skilled workforce in biomedical and clinical research, encouraging applications from underrepresented groups. Interested applicants must submit their proposals by May 7, 2027, and can find additional information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00), aimed at facilitating the transition of postdoctoral fellows to independent faculty positions. This program is specifically designed for researchers with clinical or research doctoral degrees who require minimal additional mentored training and are proposing to lead independent clinical trials or studies. The award consists of two phases: the K99 phase provides up to $100,000 annually for two years of mentored research, followed by the R00 phase, which offers up to $249,000 per year for three years of independent research. Interested applicants must adhere to detailed submission guidelines and can find more information at the provided NIH link. The application deadline is October 14, 2026, and inquiries can be directed to grantsinfo@nih.gov.
    NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Pathway to Independence Award (K99/R00), a federal grant aimed at facilitating the transition of postdoctoral researchers into independent faculty positions. This program provides up to five years of support through two phases: the K99 phase offers up to two years of mentored training and research, while the R00 phase provides up to three years of independent research funding, contingent upon satisfactory progress and appointment to a qualifying faculty position. The initiative emphasizes the development of a diverse pool of skilled scientists and requires applicants to propose a significant research plan, establish a solid mentorship framework, and demonstrate institutional commitment to their career development. Interested applicants must submit their proposals by May 7, 2027, and can find additional information at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) to support innovative biomedical and clinical research projects. This grant aims to foster exploratory research that may involve significant risks but has the potential for breakthroughs or the development of novel methodologies in health-related fields. The program is crucial for advancing research that addresses pressing health challenges and encourages applications that present new scientific ideas distinct from traditional R01 projects. Eligible applicants include a wide range of institutions, including higher education institutions, nonprofits, and for-profit organizations, both domestic and foreign, with a budget limit of $275,000 over two years and a maximum request of $200,000 in any single year. Interested parties should submit their applications electronically by January 7, 2025, and can contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for further assistance.
    NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00), aimed at facilitating the transition of postdoctoral fellows into independent faculty positions in cancer research. This grant program is designed for researchers with doctoral degrees who require minimal additional mentored training, providing up to two years of support during the K99 phase followed by up to three years of independent research funding in the R00 phase. The initiative underscores NIH's commitment to strengthening the workforce in cancer research, particularly in areas such as cancer control and prevention, while ensuring that applicants present a comprehensive career development plan and mentorship strategy. Applications will open on January 14, 2024, with potential awards beginning in February 2024; interested parties can contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.